Central Garden & Pet (CENTA) Insider Sale: Ranelli Disposes 3,076 Shares
Rhea-AI Filing Summary
John R. Ranelli, a director of Central Garden & Pet Company (CENTA), reported a sale of Class A common stock on 08/25/2025. The filing shows 3,076 shares of Class A Common Stock were sold at an aggregate range of prices between $32.53 and $32.64 per share, leaving beneficial ownership of 1,427 Class A shares and 7,039 shares of Common Stock held indirectly by the John R. Ranelli Trust dated 12/24/97. The filing is submitted by a single reporting person and signed by an attorney-in-fact on 08/28/2025. Mr. Ranelli disclaims beneficial ownership of the trust shares except to the extent of his pecuniary interest.
Positive
- Disclosure completeness: The Form 4 includes transaction date, price range, post-transaction holdings, relationship to issuer, and signature by attorney-in-fact.
- No derivatives reported: Table II is empty, indicating no newly reported options or other derivative activity in this filing.
Negative
- Insider sale: A director sold 3,076 Class A shares, which reduces his reported direct Class A stake.
- Limited detail on execution: The filing provides a price range but not the exact per-trade allocation of shares within that range, requiring staff inquiry for full granularity.
Insights
TL;DR: Director sold 3,076 Class A shares at about $32.53–$32.64, retaining trust holdings; transaction appears routine insider sale.
The Form 4 discloses a straightforward open-market sale coded "S" on 08/25/2025 for 3,076 Class A shares at prices in a narrow range, indicating an executed sale rather than an option exercise or derivative transaction. Post-transaction, beneficial ownership reported is 1,427 Class A shares plus 7,039 Common shares held indirectly via a trust. The filing identifies the reporting person as a director and includes the standard disclaimer of beneficial ownership regarding trust assets. No derivative positions, grants, or acquisitions are reported, and the disclosure does not indicate any material change to control or voting power.
TL;DR: Filing documents a director-level sale with remaining indirect trust holdings; signature by attorney-in-fact completes procedural requirements.
The submission meets Section 16 reporting norms: it lists relationship (Director), single filer status, transaction date (08/25/2025), and the reporting signature executed by an attorney-in-fact on 08/28/2025. The explanatory note clarifies the price range and the reporting persons disclaimer of trust ownership except for pecuniary interest. There are no indications of acceleration clauses, plan-based trades, or amendments. For governance purposes, this is a routine insider sale disclosure rather than a governance event.